Analyst firms · BTIG · CDNA
BTIG CDNA price target and rating history
CareDx Inc. (CDNA) · Health Care
BTIG rates CareDx Inc. (CDNA) Buy with a $40 price target, as of its latest action on Aug 19, 2024. It has published 3 rating actions on CDNA since July 2021, including 1 upgrade and 1 downgrade.
- Current rating
- Buy
- Price target
- $40
- Median target, all firms
- Too few
- Actions on CDNA
- 3
BTIG price target on CDNA
Every BTIG rating on CDNA
- Aug 19, 2024
- May 11, 2023DowngradeBTIG downgrades to Neutral from Buy
- Jul 20, 2021
How other firms rate CDNA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Canaccord Genuity | Buy | $65 | Sep 2, 2026 |
| Craig-Hallum | Buy | $64 | Aug 3, 2026 |
Questions about BTIG and CDNA
- What is BTIG's price target for CDNA?
- BTIG's latest stated price target for CareDx Inc. (CDNA) is $40, from its action on Aug 19, 2024.
- What is BTIG's rating on CDNA?
- BTIG rates CDNA Buy, a bullish rating, as of Aug 19, 2024.
- When did BTIG last change its view on CDNA?
- On Aug 19, 2024, BTIG upgrades to Buy from Neutral, price target $40.
More CDNA rating histories
All BTIG ratingsCDNA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.